Tweak Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| TWEAK (TNFSF12) | |
|---|---|
| Gene Symbol | TWEAK (TNFSF12) |
| Full Name | TNF Superfamily Member 12 |
| Chromosome | 17p13.1 |
| NCBI Gene ID | 8742 |
| OMIM | 602732 |
| Ensembl ID | ENSG00000125655 |
| UniProt ID | O43508 |
| Associated Diseases | Alzheimer's Disease, Multiple Sclerosis, Brain Ischemia |
TWEAK (TNF-Like Weak Inducer of Apoptosis) is a cytokine encoded by the TNFSF12 gene that belongs to the TNF superfamily. TWEAK is a multifunctional cytokine that binds to the Fn14 receptor (TWEAKR). TWEAK signaling can activate both pro-inflammatory (NF-κB, MAPK) and pro-apoptotic pathways. In the brain, TWEAK is produced by astrocytes, microglia, and neurons. TWEAK is implicated in Alzheimer's disease (promotes neuroinflammation and may affect amyloid-β metabolism), Parkinson's disease (affects dopaminergic neuron survival), and multiple sclerosis. TWEAK-Fn14 signaling promotes glial activation, cytokine production, and blood-brain barrier disruption. TWEAK levels are elevated in cerebrospinal fluid and brain tissue of AD and MS patients. The TWEAK-Fn14 axis represents a therapeutic target for neuroinflammatory conditions.
TWEAK (TNFSF12) encodes a cytokine that signals through the Fn14 receptor (TNFRSF12A) to regulate cell survival, proliferation, migration, and inflammation. In the nervous system, TWEAK-Fn14 signaling plays important roles in neuroinflammation, synaptic plasticity, and remyelination. The TWEAK/Fn14 axis is upregulated in various neurological disorders.
Expressed in neurons, astrocytes, microglia, and oligodendrocytes. Highest expression in areas of active neuroinflammation. The receptor Fn14 is induced by injury and disease.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | Elevated expression | Risk factor | Promotes neuroinflammation, may affect synaptic function |
| Multiple Sclerosis | Elevated expression | Risk factor | Involved in demyelination and remyelination processes |
| Brain Ischemia | Elevated expression | Risk factor | Mediates post-ischemic inflammation and injury |
The study of Tweak Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.